Overview
Marc Mcclelland is an Intensive Care Medicine provider in Grand Rapids, Michigan. Dr. Mcclelland has been practicing medicine for over 26 years and is rated as an Experienced provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Cystic Fibrosis, Lung Nodules, ALK-Positive Non-Small Cell Lung Cancer, and Small Cell Lung Cancer (SCLC).
His clinical research consists of co-authoring 7 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4100 Lake Dr SE Ste 200, Grand Rapids, MI 49546
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Lake Shore Pulmonology PLC
Mark Ivey is an Intensive Care Medicine provider in Spring Lake, Michigan. Dr. Ivey has been practicing medicine for over 44 years and is rated as an Advanced provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Obstructive Sleep Apnea, Central Sleep Apnea, Alpha-1 Antitrypsin Deficiency (AATD), and Irregular Sleep-Wake Syndrome.
Pulmonary And Critical Care Consultants PLLC
Ghulam Khaleeq is an Intensive Care Medicine provider in Lansing, Michigan. Dr. Khaleeq is rated as an Advanced provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Obstructive Sleep Apnea, Gastrostomy, and Endoscopy.
Pulmonary And Critical Care Consultants PLLC
Christopher Huhta is an Intensive Care Medicine provider in Lansing, Michigan. Dr. Huhta is rated as an Advanced provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Lung Nodules, Asthma in Children, and Gastrostomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Mcclelland isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Cystic FibrosisDr. Mcclelland isDistinguished. Learn about Cystic Fibrosis.
- Lung AdenocarcinomaDr. Mcclelland isDistinguished. Learn about Lung Adenocarcinoma.
- Lung NodulesDr. Mcclelland isDistinguished. Learn about Lung Nodules.
- Small Cell Lung Cancer (SCLC)Dr. Mcclelland isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Mcclelland isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- BronchiectasisDr. Mcclelland isAdvanced. Learn about Bronchiectasis.
- Chronic Obstructive Pulmonary Disease (COPD)
- EGFR Positive Lung CancerDr. Mcclelland isAdvanced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Mcclelland isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Lung CancerDr. Mcclelland isAdvanced. Learn about Lung Cancer.
- Lung MetastasesDr. Mcclelland isAdvanced. Learn about Lung Metastases.
- Experienced
- Acute Interstitial PneumoniaDr. Mcclelland isExperienced. Learn about Acute Interstitial Pneumonia.
- Acute Respiratory Distress Syndrome (ARDS)Dr. Mcclelland isExperienced. Learn about Acute Respiratory Distress Syndrome (ARDS).
- Allergic Bronchopulmonary AspergillosisDr. Mcclelland isExperienced. Learn about Allergic Bronchopulmonary Aspergillosis.
- Alpha-1 Antitrypsin Deficiency (AATD)Dr. Mcclelland isExperienced. Learn about Alpha-1 Antitrypsin Deficiency (AATD).
- AspergillosisDr. Mcclelland isExperienced. Learn about Aspergillosis.
- Atypical PneumoniaDr. Mcclelland isExperienced. Learn about Atypical Pneumonia.